10-Q Filing

BNB PLUS CORP. CIK: 744452 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-011890`
Period End Date	20191231
Filing Date	20200206
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	apdn-20191231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 35 Cash Flow Statement 58 Stockholders Equity 19

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.50K	USD	Point-in-time
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.50K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.66M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$558.99K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $4,500 at December 31, 2019 and September 30, 2019, respectively	`AccountsReceivableNetCurrent`	$273.97K	USD	Point-in-time
Accounts receivable, net of allowance of $4,500 at December 31, 2019 and September 30, 2019, respectively	`AccountsReceivableNetCurrent`	$839.95K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$82.68K	USD	Point-in-time
Inventories	`InventoryNet`	$142.63K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$618.08K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$604.74K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.15M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	1.20M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$184.10K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.49M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$226.22K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.49M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	1.20M	shares	Point-in-time
Deferred offering costs	`DeferredCosts`	$109.70K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$62.35K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$62.35K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$734.77K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$702.41K	USD	Point-in-time
Total Assets	`Assets`	$10.87M	USD	Point-in-time
Total Assets	`Assets`	$3.56M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.62M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.05M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$455.05K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$628.99K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.25M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.51M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$621.97K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$659.69K	USD	Point-in-time
Secured convertible notes payable, net of debt issuance costs	`ConvertibleLongTermNotesPayable`	$1.44M	USD	Point-in-time
Secured convertible notes payable, net of debt issuance costs	`ConvertibleLongTermNotesPayable`	$1.48M	USD	Point-in-time
Secured convertible notes payable, recorded at fair value	`SecuredConvertibleNotesPayableNoncurrentFairValueDisclosures`	$102.78K	USD	Point-in-time
Total liabilities	`Liabilities`	$4.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.65M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0 shares issued and outstanding as of December 31, 2019 and September 30, 2019 respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0 shares issued and outstanding as of December 31, 2019 and September 30, 2019 respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 500,000,000 shares authorized; 3,485,399 and 1,200,399 shares issued and outstanding as of December 31, 2019 and September 30, 2019, respectively	`CommonStockValue`	$3.48K	USD	Point-in-time
Common stock, par value $0.001 per share; 500,000,000 shares authorized; 3,485,399 and 1,200,399 shares issued and outstanding as of December 31, 2019 and September 30, 2019, respectively	`CommonStockValue`	$1.20K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$266.70M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$255.96M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-256.81M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-259.47M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity (deficit):	`StockholdersEquity`	$-841.46K	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity (deficit):	`StockholdersEquity`	$7.23M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-7.07K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-7.04K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$754.50K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$766.02K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Total liabilities and (deficit) equity	`LiabilitiesAndStockholdersEquity`	$3.56M	USD	Point-in-time
Total liabilities and (deficit) equity	`LiabilitiesAndStockholdersEquity`	$10.87M	USD	Point-in-time

Income Statement 35 line items

Line Item	Tag	Value	Unit	Period
Interest (expense) income, related party interest	`InterestIncomeRelatedParty`	$23.47K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$884.32K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$633.52K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$153.49K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$232.03K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.37M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.08M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$564.43K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$709.56K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$135.05K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$75.07K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.01M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.93M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.61M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-3.20M	USD	1 Quarter
Interest (expense) income, net (including related party of $23,470 for the three month period ended December 31, 2018)	`InterestIncomeExpenseNet`	$-29.09K	USD	1 Quarter
Interest (expense) income, net (including related party of $23,470 for the three month period ended December 31, 2018)	`InterestIncomeExpenseNet`	$-31.61K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-6.55K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-22.23K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.23M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.66M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-3.23M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.66M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-30.00	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-2.66M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-3.23M	USD	1 Quarter
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$-2.84K	USD	1 Quarter
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.67M	USD	1 Quarter
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.23M	USD	1 Quarter
Net loss per share applicable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-4.25	USD	1 Quarter
Net loss per share applicable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.12	USD	1 Quarter
Weighted average shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.38M	shares	1 Quarter
Weighted average shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	761,769.00	shares	1 Quarter

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-3.23M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.66M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$135.05K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$75.07K	USD	1 Quarter
Stock based compensation expense	`ShareBasedCompensation`	$205.49K	USD	1 Quarter
Stock based compensation expense	`ShareBasedCompensation`	$490.24K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$4.49K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$6.16K	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$-8.63K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-565.98K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-879.81K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-59.95K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$3.92K	USD	1 Quarter
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-6.31K	USD	1 Quarter
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$13.34K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$198.71K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-793.89K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-173.94K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$18.58K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.73M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.51M	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$52.05K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-52.05K	USD	1 Quarter
Net proceeds from secured convertible promissory notes, related parties	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$550.00K	USD	1 Quarter
Net proceeds from secured convertible promissory notes, related parties	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	1 Quarter
Repayment of secured convertible promissory notes	`RepaymentsOfNotesPayable`	$107.80K	USD	1 Quarter
Repayment of secured convertible promissory notes	`RepaymentsOfNotesPayable`	-	USD	1 Quarter
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$2.49M	USD	1 Quarter
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$10.94M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.84M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.04M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.10M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.48M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.66M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.14M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.66M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.66M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.14M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.66M	USD	Point-in-time
Cash paid during year for interest	`InterestPaid`	-	USD	1 Quarter
Cash paid during year for interest	`InterestPaid`	-	USD	1 Quarter
Cash paid during year for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid during year for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Interest paid in kind	`PaidInKindInterest`	$35.62K	USD	1 Quarter
Interest paid in kind	`PaidInKindInterest`	-	USD	1 Quarter
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	-	USD	1 Quarter
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	$2.84K	USD	1 Quarter
Impact of adoption of new accounting pronouncements included in accumulated deficit	`ImpactOfAdoptionOfNewAccountingPronouncementsIncludedInAccumulatedDeficitNonCashFinancingActivities`	-	USD	1 Quarter
Impact of adoption of new accounting pronouncements included in accumulated deficit	`ImpactOfAdoptionOfNewAccountingPronouncementsIncludedInAccumulatedDeficitNonCashFinancingActivities`	$493.22K	USD	1 Quarter
Deferred offering costs reclassified to additional paid in capital	`ReclassificationOfDeferredOfferingCostToAdditionalPaidInCapital`	$109.70K	USD	1 Quarter
Deferred offering costs reclassified to additional paid in capital	`ReclassificationOfDeferredOfferingCostToAdditionalPaidInCapital`	-	USD	1 Quarter
Public offering costs incurred, and included in accounts payable	`OfferingCostsIncurredAndIncludedInAccountsPayable`	$231.52K	USD	1 Quarter
Public offering costs incurred, and included in accounts payable	`OfferingCostsIncurredAndIncludedInAccountsPayable`	$303.21K	USD	1 Quarter

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$754.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$766.02K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	3.49M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	1.20M	shares	Point-in-time
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-10.53M	USD	1 Quarter
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-2.26M	USD	1 Quarter
Impact of adoption of new accounting pronouncements included in accumulated deficit	`ImpactOfAdoptionOfNewAccountingPronouncementsIncludedInAccumulatedDeficit`	$-493.22K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$490.24K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$205.49K	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.23M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.66M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$754.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$766.02K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	3.49M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	1.20M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.